Catalyst Award Advisors

Naomi Bardach MD, MAS

Steven Basta MBA

Chief Executive Officer of Menlo Therapeutics, Inc.

Doug Bauer MD

School of Medicine
Epidemiology and Biostatistics, Medicine / General Internal Medicine

Alexis Beatty MD, MAS

Rick Beberman MBA, MAcc

Digital Health Consultant

Daniel Becker MD, JD

Partner, Fenwick & West LLP

Catherine Behrens PhD, MD

Senior Director Clinical Research, Roche Molecular Systems

Madhavi Bellamkonda MA

Associate Director, Regulatory Affairs, Abbott Vascular

Ellen Berg PhD

Chief Scientific Officer, Translational Biology at Eurofins DiscoverX

Beth Berrean MBA

Design Strategist , UCSF

Kirsten Bibbins-Domingo PhD, MD, MAS

School of Medicine
Medicine / General Internal Medicine

Robert Blazej PhD

For the past four years, Robert directed Novozymes’ Digital Biotechnology unit in San Francisco and their global biotechnology scouting team. Previously, Robert was CEO of Allopartis Biotechnologies, a company he co-founded with the vision that mircrodoplets would transform the scale and pace of life science research. Allopartis was acquired by Novozymes in 2013.

Robert earned his Ph.D. in 2006 in Bioengineering jointly from UC Berkeley and UC San Francisco. His graduate research focused on the design, implementation and characterization of microfluidic systems for next-generation DNA sequencing. Blazej is a published contributor to the human, drosophila, and canine genome projects, with his work on integrated microfluidic DNA sequencing featured on the cover of PNAS and in Nature.

Robert Blazej PhD

Partner at Mission Bay Capital, Director at MBC Biolabs

Sarah Bodary PhD

Principal, Founder, Darwin Bodary Consulting

Sonia Bonifacio MD

Mufaddal Bootwala MBA

Strategic Director of Marketing, Portola

William Boyle PhD

Associate Professor, Department of Medicine, David Geffen School of Medicine UCLA

Tilmann Brotz PhD, MS

Principal, Konzept Drug Development Consulting

Rebecca Brown MD, MPH

School of Medicine
Geriatrics

Joelle Brown PhD

School of Medicine
Epidemiology & Biostatistics

Teresa Burgess PhD

CSO and Co-founder, Paradigm Shift Therapeutics, LLC

Daniel Burnett MD, MBA

CEO, Theranova

Nancy Byl PhD, PT

Professor Emeritus, School of Medicine, UCSF

Carolyn Calfee MD, MAS

Rachael Callcut MD, MSPH

School of Medicine
Surgery / General Surgery

Ivor Caro MD

Senior Medical Director, Genentech

Adithya Cattamanchi MD, MAS

Benjamin Chaffee DDS, MPH, PhD

School of Dentistry
Preventive and Restorative Dentistry

Steven Chan MD, MBA

Digital Health & Behavioral Sciences Research, UCSF

Maria Chao DrPH, MPA

Yvonne Cheng MD, MPH

Julie Cherrington PhD, MS

President and CEO, Arch Oncology

Kit Chesla RN, PhD, FAAN

School of Nursing
Family Health Care Nursing

Elaine Cheung MS

Associate Director, Business and Corporate Development, Illumina, Inc.

Al Chin MD

Co-Founder, Pavilion Medical Innovations, LLC

Richard Chin MD, MA

Founder & CEO, Kindred Bio

Winston Chiong PhD, MD

Gavin Choy PharmD, MBA

Chief Operating Officer
Beyond Cancer, Ltd.

Stephanie Christenson MD

School of Medicine
Medicine / Pulmonary & Critical Care Medicine

Sharon Chung MD, MAS

Jennifer Comiskey

Director - MDL, McKinsey & Company

Hillary Copp MD, MS

Douglas Crawford PhD

Managing Director, Mission Bay Capital

Jennifer Cygan PhD

Senior Director, Business Development, Calico

Joseph Dal Porto PhD

Site Head, Pfizer Center for Therapeutic Innovation - San Francisco

Nipun Davar PhD, MBA

Senior Vice President at Astex Pharmaceuticals

Rohan Desai MBA

Associate Director Regulatory Affairs, Abbott Vascular

Tejal Desai PhD

Chair of the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco